Approval also marks the second NGS-based companion diagnostic to identify RET-fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC) CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET-fusion positive locally […]

New BD® Research Cloud provides scientists with an integrated ecosystem that allows for optimizing panel design, collaboration and analysis FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher quality experiments […]

Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of a new computational analysis method for profiling more than a million tandem repeats (TRs) across the human genome using PacBio’s native long-read HiFi sequencing data. The Tandem […]

The PIPseq™ T100 kits enable any researcher to easily perform large, complex single-cell transcriptomic applications in a single reaction with no expensive capital equipment Watertown, MA – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces the launch of a novel 100,000 cell product for 3′ […]

LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that Steve Quinlan, the company’s Chief Financial Officer, has announced his intent to retire effective May 31, 2023, at the conclusion of the company’s fiscal year. Quinlan has served as Neogen’s CFO since 2011, leading the company through more than 30 acquisitions, including the company’s recent acquisition […]

Element Biosciences, Inc. – developer of an innovative DNA sequencing platform set to disrupt the genomics industry – today announced updated specifications to their AVITI™ System, increasing the platform’s specifications from 800 million reads per flow cell to 1.0 billion reads per flow cell*, further reducing the price per Gigabase (or run). “We launched with a conservative specification […]

Cell-Based P53 Reporter Assay Provides Insight for Pre-Clinical Cancer Drug Discovery State College, PA – INDIGO Biosciences announced today the addition of a new cell-based luciferase reporter assay for Human Tumor Protein P53. The new assay is part of INDIGO’s portfolio of assays for cancer research. The bioscience company’s cell-based luciferase reporter assays are especially useful during the […]

New genomics resources to improve diversity and to increase representation of Indigenous people in reference data set Improving genomic databases A team led by the Garvan Institute of Medical Research is set to establish a new genomic database for Indigenous Australians. The project will be jointly run with the Australian National University’s National Centre for […]

SAN DIEGO and SAN JOSE — Bionano Laboratories and OptraHEALTH today announced their collaboration to utilize HealthFAX’s proprietary AI platform to enhance genetic counseling services and improve care for patients receiving diagnostic services through the Bionano Laboratories. Bionano Laboratories utilizes cutting-edge technologies to provide genetic diagnostics in both clinical and research settings. Bionano Laboratories intends […]

SHENZHEN, China — MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. As one of the sequencers* with the fastest speed among those with the same throughput in the world, DNBSEQ-G99* is especially suitable for targeted gene sequencing and small genome sequencing, […]